GlaxoSmithKline (GSK) recently announced that the European Medicine Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has released a…
Articles by Patrícia Silva, PhD
Patients suffering from chronic thromboembolic pulmonary hypertension (CTEPH) or recurrent CTEPH in Wales now have access to Bayer’s therapy Adempas (riociguat)…
North Bergen, New Jersey locals Carlos Torres and Martha Gonzalez reported in a recent press…
Actelion Pharmaceuticals, a biopharmaceutical company developing pulmonary arterial hypertension (PAH) therapies, recently announced the presentation of further data from…
Brooklyn Brazilian Jiu-Jitsu, the city’s leading consortium of martial arts schools across Bensonhurst, Cobble Hill, Clinton Hill, Dyker Heights and…
The Pulmonary Hypertension Association (PHA) is currently hosting the 2015 PH Professional Network (PHPN) Symposium, which began on Thursday, September 17…
Sunshine Heart, Inc., an early-stage medical device company focused on developing, manufacturing and commercializing the C-Pulse System for treatment of Class…
The European Society of Cardiology (ESC) together with the European Respiratory Society (ERS) recently launched a new treatment algorithm…
Gilead Sciences, Inc. recently announced the publication of data in The New England Journal of Medicine…
Actelion Pharmaceuticals Ltd recently announced in a press release that new data on its investigational drug selexipag (Uptravi®)…
Results from a recent study published in the journal Circulation: Cardiovascular Imaging showed that pediatric patients with…
A new study recently published in the Chinese Medical Journal revealed that a 6-month warfarin treatment might…